After a brief stint in the top cancer research spot at Gilead, Valeria Fantin jumps over to Sanofi
Just a few months ago, Gilead said it was setting up shop in North Carolina’s Research Triangle, with plans to hire 300 employees in the process. It can now add a new head of oncology research to that list.
After a short stint at Gilead, Valeria Fantin is jumping over to Sanofi as the pharma giant’s newest global head of oncology research. The Dartmouth grad has bounced around a few times over the last decade or so, racking up experience at some of the biggest companies in the industry and adding a handful of blockbusters and first-in-class drugs to her résumé.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,500+ biopharma pros reading Endpoints daily — and it's free.